BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

343 related articles for article (PubMed ID: 31390228)

  • 21. Palmitoylethanolamide Promotes a Proresolving Macrophage Phenotype and Attenuates Atherosclerotic Plaque Formation.
    Rinne P; Guillamat-Prats R; Rami M; Bindila L; Ring L; Lyytikäinen LP; Raitoharju E; Oksala N; Lehtimäki T; Weber C; van der Vorst EPC; Steffens S
    Arterioscler Thromb Vasc Biol; 2018 Nov; 38(11):2562-2575. PubMed ID: 30354245
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Elevated expression of macrophage MERTK exhibits profibrotic effects and results in defective regulation of efferocytosis function in pulmonary fibrosis.
    She Y; Xu X; Yu Q; Yang X; He J; Tang XX
    Respir Res; 2023 Apr; 24(1):118. PubMed ID: 37120511
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Differential activation of mitogen-activated protein kinases in smooth muscle cells by angiotensin II: involvement of p22phox and reactive oxygen species.
    Viedt C; Soto U; Krieger-Brauer HI; Fei J; Elsing C; Kübler W; Kreuzer J
    Arterioscler Thromb Vasc Biol; 2000 Apr; 20(4):940-8. PubMed ID: 10764657
    [TBL] [Abstract][Full Text] [Related]  

  • 24. MERTK tyrosine kinase receptor together with TIM4 phosphatidylserine receptor mediates distinct signal transduction pathways for efferocytosis and cell proliferation.
    Nishi C; Yanagihashi Y; Segawa K; Nagata S
    J Biol Chem; 2019 May; 294(18):7221-7230. PubMed ID: 30846565
    [TBL] [Abstract][Full Text] [Related]  

  • 25. MerTK cleavage limits proresolving mediator biosynthesis and exacerbates tissue inflammation.
    Cai B; Thorp EB; Doran AC; Subramanian M; Sansbury BE; Lin CS; Spite M; Fredman G; Tabas I
    Proc Natl Acad Sci U S A; 2016 Jun; 113(23):6526-31. PubMed ID: 27199481
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Angiotensin-(1-7) modulates renal vascular resistance through inhibition of p38 mitogen-activated protein kinase in apolipoprotein E-deficient mice.
    Potthoff SA; Fähling M; Clasen T; Mende S; Ishak B; Suvorava T; Stamer S; Thieme M; Sivritas SH; Kojda G; Patzak A; Rump LC; Stegbauer J
    Hypertension; 2014 Feb; 63(2):265-72. PubMed ID: 24191281
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Antioxidants inhibit JNK and p38 MAPK activation but not ERK 1/2 activation by angiotensin II in rat aortic smooth muscle cells.
    Kyaw M; Yoshizumi M; Tsuchiya K; Kirima K; Tamaki T
    Hypertens Res; 2001 May; 24(3):251-61. PubMed ID: 11409648
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Enhanced efferocytosis of apoptotic cardiomyocytes through myeloid-epithelial-reproductive tyrosine kinase links acute inflammation resolution to cardiac repair after infarction.
    Wan E; Yeap XY; Dehn S; Terry R; Novak M; Zhang S; Iwata S; Han X; Homma S; Drosatos K; Lomasney J; Engman DM; Miller SD; Vaughan DE; Morrow JP; Kishore R; Thorp EB
    Circ Res; 2013 Sep; 113(8):1004-12. PubMed ID: 23836795
    [TBL] [Abstract][Full Text] [Related]  

  • 29. BMS794833 inhibits macrophage efferocytosis by directly binding to MERTK and inhibiting its activity.
    Bae SH; Kim JH; Park TH; Lee K; Lee BI; Jang H
    Exp Mol Med; 2022 Sep; 54(9):1450-1460. PubMed ID: 36056187
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Targeted delivery of MerTK protein via cell membrane engineered nanoparticle enhances efferocytosis and attenuates atherosclerosis in diabetic ApoE
    Qiu S; Liu J; Chen J; Li Y; Bu T; Li Z; Zhang L; Sun W; Zhou T; Hu W; Yang G; Yuan L; Duan Y; Xing C
    J Nanobiotechnology; 2024 Apr; 22(1):178. PubMed ID: 38614985
    [TBL] [Abstract][Full Text] [Related]  

  • 31. MerTK Cleavage on Resident Cardiac Macrophages Compromises Repair After Myocardial Ischemia Reperfusion Injury.
    DeBerge M; Yeap XY; Dehn S; Zhang S; Grigoryeva L; Misener S; Procissi D; Zhou X; Lee DC; Muller WA; Luo X; Rothlin C; Tabas I; Thorp EB
    Circ Res; 2017 Sep; 121(8):930-940. PubMed ID: 28851810
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The Important Role of Phosphatidylserine, ADAM17, TNF-Alpha, and Soluble MER on Efferocytosis Activity in Central Obesity.
    Purnama CA; Meiliana A; Barliana MI; Lestari K; Wijaya A
    J Obes; 2024; 2024():1424404. PubMed ID: 38550672
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A+T rich interaction domain protein 3a (Arid3a) impairs Mertk-mediated efferocytosis in cholestasis.
    Chen R; Huang B; Lian M; Wei Y; Miao Q; Liang J; Ou Y; Liang X; Zhang H; Li Y; Xiao X; Wang Q; You Z; Chai J; Gershwin ME; Tang R; Ma X
    J Hepatol; 2023 Dec; 79(6):1478-1490. PubMed ID: 37659731
    [TBL] [Abstract][Full Text] [Related]  

  • 34. ERK and p38 MAPK, but not NF-kappaB, are critically involved in reactive oxygen species-mediated induction of IL-6 by angiotensin II in cardiac fibroblasts.
    Sano M; Fukuda K; Sato T; Kawaguchi H; Suematsu M; Matsuda S; Koyasu S; Matsui H; Yamauchi-Takihara K; Harada M; Saito Y; Ogawa S
    Circ Res; 2001 Oct; 89(8):661-9. PubMed ID: 11597988
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Angiotensin-(1-7) stimulates cholesterol efflux from angiotensin II-treated cholesterol-loaded THP-1 macrophages through the suppression of p38 and c-Jun N-terminal kinase signaling.
    Yang HY; Bian YF; Xiao CS; Liang B; Zhang N; Gao F; Yang ZM
    Mol Med Rep; 2015 Jul; 12(1):1387-92. PubMed ID: 25779847
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Selective activation of CB2 receptor improves efferocytosis in cultured macrophages.
    Jiang L; Chen Y; Huang X; Yuan A; Shao Q; Pu J; He B
    Life Sci; 2016 Sep; 161():10-8. PubMed ID: 27474129
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Overexpression of MERTK receptor tyrosine kinase in epithelial cancer cells drives efferocytosis in a gain-of-function capacity.
    Nguyen KQ; Tsou WI; Calarese DA; Kimani SG; Singh S; Hsieh S; Liu Y; Lu B; Wu Y; Garforth SJ; Almo SC; Kotenko SV; Birge RB
    J Biol Chem; 2014 Sep; 289(37):25737-49. PubMed ID: 25074939
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Defective Efferocytosis in a Murine Model of Sjögren's Syndrome Is Mediated by Dysfunctional Mer Tyrosine Kinase Receptor.
    Witas R; Rasmussen A; Scofield RH; Radfar L; Stone DU; Grundahl K; Lewis D; Sivils KL; Lessard CJ; Farris AD; Nguyen CQ
    Int J Mol Sci; 2021 Sep; 22(18):. PubMed ID: 34575873
    [TBL] [Abstract][Full Text] [Related]  

  • 39. ODC (Ornithine Decarboxylase)-Dependent Putrescine Synthesis Maintains MerTK (MER Tyrosine-Protein Kinase) Expression to Drive Resolution.
    Yurdagul A; Kong N; Gerlach BD; Wang X; Ampomah P; Kuriakose G; Tao W; Shi J; Tabas I
    Arterioscler Thromb Vasc Biol; 2021 Mar; 41(3):e144-e159. PubMed ID: 33406854
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Angiotensin II stimulates the synthesis of vascular endothelial growth factor through the p38 mitogen activated protein kinase pathway in cultured mouse podocytes.
    Kang YS; Park YG; Kim BK; Han SY; Jee YH; Han KH; Lee MH; Song HK; Cha DR; Kang SW; Han DS
    J Mol Endocrinol; 2006 Apr; 36(2):377-88. PubMed ID: 16595708
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.